Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
The New England Journal of Medicine
|
March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Bryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Neurosurgical Focus
|
March 1, 2025
Telerehabilitation and cost analysis in global neurosurgery: a systematic review and meta-analysis of 40,537 patients
Shahaan S Razak, Fabricio Garcia-Torrico, Caitlyn J Smith, et al.
JCI Insight
|
March 15, 2019
Chimeric antigen receptor costimulation domains modulate human regulatory T cell function
Angela C Boroughs, Rebecca C Larson, Bryan D Choi, et al.
Cancer Immunology, Immunotherapy : CII
|
January 14, 2016
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy
Anirudh Saraswathula, Elizabeth A Reap, Bryan D Choi, et al.
Plos One
|
March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice
Luis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
Luis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Blood
|
July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
Matthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
The New England Journal of Medicine
|
March 13, 2024
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Bryan D Choi, Elizabeth R Gerstner, Matthew J Frigault, et al.
Neurosurgical Focus
|
March 1, 2025
Telerehabilitation and cost analysis in global neurosurgery: a systematic review and meta-analysis of 40,537 patients
Shahaan S Razak, Fabricio Garcia-Torrico, Caitlyn J Smith, et al.
JCI Insight
|
March 15, 2019
Chimeric antigen receptor costimulation domains modulate human regulatory T cell function
Angela C Boroughs, Rebecca C Larson, Bryan D Choi, et al.
Cancer Immunology, Immunotherapy : CII
|
January 14, 2016
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy
Anirudh Saraswathula, Elizabeth A Reap, Bryan D Choi, et al.
Plos One
|
March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice
Luis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide
Luis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Blood
|
July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
Matthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Cancers
|
July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma
Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Page
of 13